BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
77 hedge funds and large institutions have $40.8M invested in BioDelivery Sciences International, Inc. in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 19 closing their positions.
62% more call options, than puts
Call options by funds: $352K | Put options by funds: $217K
0% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 22
9% less funds holding
Funds holding: 85 → 77 (-8)
32% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 19
45% less capital invested
Capital invested by funds: $74.2M → $40.8M (-$33.4M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$5.31M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.94M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$1.32M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.02M |
| 5 |
BC
Broadfin Capital
New York
|
+$429K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$3.67M |
| 2 |
EC
Engaged Capital
Newport Beach,
California
|
-$3.45M |
| 3 |
Renaissance Technologies
New York
|
-$2.51M |
| 4 |
Millennium Management
New York
|
-$2.4M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$2.17M |
BDSI Hedge Fund Activity: Q4 2016 in Review
77 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2016, worth a combined $40.8M — down 45% from $74.2M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of BDSI and 13 opened new positions — a net loss of 6 holders — while 22 trimmed existing stakes and 22 added.
The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $5.31M. The largest seller was Falcon Point Capital, exiting entirely with an estimated $3.67M sold.
- 77 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2016, down from 85 in Q3 2016.
- Funds reported $40.8M of BioDelivery Sciences International, Inc. stock for Q4 2016, down 45% quarter-over-quarter.
- 13 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2016 and 19 closed out, a net change of -6 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q4 2016 was Stonepine Capital Management, an estimated $5.31M added.
- The largest BioDelivery Sciences International, Inc. seller in Q4 2016 was Falcon Point Capital, an estimated $3.67M sold.
Based on aggregated 13F filings for Q4 2016.